191 related articles for article (PubMed ID: 33124659)
1. A molecular map of lung neuroendocrine neoplasms.
Gabriel AAG; Mathian E; Mangiante L; Voegele C; Cahais V; Ghantous A; McKay JD; Alcala N; Fernandez-Cuesta L; Foll M
Gigascience; 2020 Oct; 9(11):. PubMed ID: 33124659
[TBL] [Abstract][Full Text] [Related]
2. A molecular phenotypic map of malignant pleural mesothelioma.
Di Genova A; Mangiante L; Sexton-Oates A; Voegele C; Fernandez-Cuesta L; Alcala N; Foll M
Gigascience; 2022 Dec; 12():. PubMed ID: 36705549
[TBL] [Abstract][Full Text] [Related]
3. Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation.
Moonen L; Mangiante L; Leunissen DJG; Lap LMV; Gabriel A; Hillen LM; Roemen GM; Koch A; van Engeland M; Dingemans AC; Foll M; Alcala N; Fernandez-Cuesta L; Derks JL; Speel EM
Int J Cancer; 2022 Jun; 150(12):1987-1997. PubMed ID: 35076935
[TBL] [Abstract][Full Text] [Related]
4. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.
Simbolo M; Barbi S; Fassan M; Mafficini A; Ali G; Vicentini C; Sperandio N; Corbo V; Rusev B; Mastracci L; Grillo F; Pilotto S; Pelosi G; Pelliccioni S; Lawlor RT; Tortora G; Fontanini G; Volante M; Scarpa A; Bria E
J Thorac Oncol; 2019 Sep; 14(9):1651-1661. PubMed ID: 31085341
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
7. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.
Alcala N; Leblay N; Gabriel AAG; Mangiante L; Hervas D; Giffon T; Sertier AS; Ferrari A; Derks J; Ghantous A; Delhomme TM; Chabrier A; Cuenin C; Abedi-Ardekani B; Boland A; Olaso R; Meyer V; Altmuller J; Le Calvez-Kelm F; Durand G; Voegele C; Boyault S; Moonen L; Lemaitre N; Lorimier P; Toffart AC; Soltermann A; Clement JH; Saenger J; Field JK; Brevet M; Blanc-Fournier C; Galateau-Salle F; Le Stang N; Russell PA; Wright G; Sozzi G; Pastorino U; Lacomme S; Vignaud JM; Hofman V; Hofman P; Brustugun OT; Lund-Iversen M; Thomas de Montpreville V; Muscarella LA; Graziano P; Popper H; Stojsic J; Deleuze JF; Herceg Z; Viari A; Nuernberg P; Pelosi G; Dingemans AMC; Milione M; Roz L; Brcic L; Volante M; Papotti MG; Caux C; Sandoval J; Hernandez-Vargas H; Brambilla E; Speel EJM; Girard N; Lantuejoul S; McKay JD; Foll M; Fernandez-Cuesta L
Nat Commun; 2019 Aug; 10(1):3407. PubMed ID: 31431620
[TBL] [Abstract][Full Text] [Related]
8. Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm.
Rosiek V; Kogut A; Kos-Kudła B
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444393
[TBL] [Abstract][Full Text] [Related]
9. Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
Cros J; Théou-Anton N; Gounant V; Nicolle R; Reyes C; Humez S; Hescot S; Thomas de Montpréville V; Guyétant S; Scoazec JY; Guyard A; de Mestier L; Brosseau S; Mordant P; Castier Y; Gentien D; Ruszniewski P; Zalcman G; Couvelard A; Cazes A
Neuroendocrinology; 2021; 111(1-2):158-169. PubMed ID: 32015233
[TBL] [Abstract][Full Text] [Related]
10. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
[TBL] [Abstract][Full Text] [Related]
11. Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms.
Ferencz B; Megyesfalvi Z; Csende K; Fillinger J; Poór V; Lantos A; Pipek O; Sólyom-Tisza A; Rényi-Vámos F; Schelch K; Lang C; Schwendenwein A; Boettiger K; László V; Hoetzenecker K; Döme B; Berta J
Lung Cancer; 2023 Jul; 181():107263. PubMed ID: 37270937
[TBL] [Abstract][Full Text] [Related]
12. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
[TBL] [Abstract][Full Text] [Related]
13. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
[TBL] [Abstract][Full Text] [Related]
14. Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors.
Asiedu MK; Thomas CF; Dong J; Schulte SC; Khadka P; Sun Z; Kosari F; Jen J; Molina J; Vasmatzis G; Kuang R; Aubry MC; Yang P; Wigle DA
Clin Cancer Res; 2018 Apr; 24(7):1691-1704. PubMed ID: 29351916
[No Abstract] [Full Text] [Related]
15. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
[TBL] [Abstract][Full Text] [Related]
16. Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups.
Centonze G; Biganzoli D; Prinzi N; Pusceddu S; Mangogna A; Tamborini E; Perrone F; Busico A; Lagano V; Cattaneo L; Sozzi G; Roz L; Biganzoli E; Milione M
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987854
[TBL] [Abstract][Full Text] [Related]
17. [Genomics of neuroendocrine tumors of the lung and gastrointestinal tract: similarities and differences].
Tímár J; Patócs A
Magy Onkol; 2018 Jul; 62(2):77-82. PubMed ID: 30027934
[TBL] [Abstract][Full Text] [Related]
18. Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids.
Naraev BG; Ramirez RA; Kendi AT; Halfdanarson TR
Clin Lung Cancer; 2019 May; 20(3):e376-e392. PubMed ID: 30910575
[TBL] [Abstract][Full Text] [Related]
19. Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?
Sun TY; Hendifar A; Padda SK
Curr Oncol Rep; 2022 Jul; 24(7):819-824. PubMed ID: 35305210
[TBL] [Abstract][Full Text] [Related]
20. Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma.
Zhang Y; Wang W; Hu Q; Liang Z; Zhou P; Tang Y; Jiang L
BMC Cancer; 2022 Mar; 22(1):321. PubMed ID: 35331190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
